A Premier Boutique
Investment Bank
Specializing in PIPEs, Reverse Mergers,
M&A, Private Equity & LP Equity for CRE
  • HMNY MoviePass
  • Phase Rx
  • PallAdium Capital Advisor
  • PallAdium Capital Advisor

Palladium Capital Advisors Acts as Co-Placement Agent on Protein Polymer Technologies” $7.75 Million Private Placement

Apr. 18, 2005:

tomb_proteinApril 18, 2005: Protein Polymer Technologies (OTCBB:PPTI) announced today the final closing of a private placement of common stock and warrants yielding total gross proceeds of approximately $7.75 million in which Palladium Capital Advisors acted as co-placement agent. Protein Polymer Technologies is a company focused on high performance bioactive devices designed for improved surgical outcomes. The net proceeds will be used to fund Protein Polymer’s research and clinical programs, and for general corporate purposes, including potential acquisitions. Investors in the private placement included both institutional and individual accredited investors.


See full press release…
For More information on Protein Polymer Technologies…